Clinical Trials

Clinical Trials

We believe that addressing the disruption of the intestinal barrier can fundamentally change the way diseases are treated and establish new standards of patient care.


Post-Surgical Intraabdominal Adhesions

Ongoing Phase 2 study to evaluate LB1148 for its effect on post-operative ileus and intra-abdominal adhesions and return of gastrointestinal function in subjects undergoing elective bowel resection (PROFILE)

Randomized, Double-Blind, Placebo-Controlled, Multi-Site Study
Up to 200 patients ∣ ~70 patients with a planned adhesion evaluation ∣ ~17 sites in the U.S.

Evaluate LB1148 to reduce the formation of post-surgical intra-abdominal adhesions and accelerate the return of GI function in subjects undergoing elective bowel resection with planned stoma take-down

Primary Endpoint: Extent and severity of adhesions score

For complete study details, please view the study listing on NCT02836470

LB1148 Reduced Adhesion Formation in GI Surgery Patients

If you are interested in learning more about our clinical trials, please contact Palisade Bio at: or 858.704.4900